

RxSight (NASDAQ:RXST) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of RxSight (NASDAQ:RXST) through any online brokerage.
Other companies in RxSight’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).
RxSight has a consensus price target of $9.23.
The stock price for RxSight (NASDAQ: RXST) is $4.54 last updated November 5, 2026 at 4:00 PM EST.
There are no upcoming dividends for RxSight.
RxSight does not have any upcoming earnings scheduled.
There is no upcoming split for RxSight.
RxSight is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients...